Comparative Pharmacology
Head-to-head clinical analysis: LACTULOSE versus LAXILOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LACTULOSE versus LAXILOSE.
LACTULOSE vs LAXILOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lactulose is a non-absorbable disaccharide that is metabolized by colonic bacteria to short-chain fatty acids, primarily lactic acid and acetic acid, resulting in an osmotic effect that increases stool water content and softens stools. In hepatic encephalopathy, lactulose acidifies the colonic lumen, converting NH3 to NH4+, which is poorly absorbed, and reduces systemic ammonia levels.
Laxilose (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic, acetic, formic acids), which osmotically draw water into the bowel lumen, stimulating peristalsis and softening stools. Additionally, in hepatic encephalopathy, colonic acidification traps ammonia (NH3) as ammonium (NH4+), reducing systemic ammonia absorption.
Constipation: 15-30 mL (10-20 g) orally once daily, increased to 45-60 mL (30-40 g) daily if needed. Hepatic encephalopathy: 30-45 mL (20-30 g) orally 3-4 times daily; titrate to produce 2-3 soft stools daily.
10-20 g (15-30 mL) orally once daily; may increase to 40 g (60 mL) daily in divided doses.
None Documented
Clinical Note
moderateL-Glutamine + Lactulose
"The therapeutic efficacy of Lactulose can be decreased when used in combination with L-Glutamine."
None Documented
1-2 hours (terminal elimination half-life for lactulose). However, its clinical effect is not dependent on systemic half-life; the drug acts locally in the colon.
Terminal elimination half-life is 2.5-4 hours in patients with normal renal function; prolonged to up to 20 hours in severe renal impairment.
Primarily fecal (unaltered, >90%). Minimal renal excretion (<5% as metabolites). Very small amount (approximately 3%) excreted in urine as unchanged drug.
Primarily renal excretion, with approximately 40% of the dose recovered as unchanged drug in urine; biliary/fecal excretion accounts for the remainder, including metabolites.
Category C
Category C
Laxative
Laxative